1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Balstilmab: new trials by email Literature Review of Balstilmab trials Research Report on Balstilmab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer Ivermectin, Balstilmab, Pembrolizumab - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma | Phase 1 / Phase 2 | Recruiting | Yuan Yuan | 34 | 2023-10-13 | 2026-08-05 |
Triple Negative Breast Neoplasms (1)
Yuan Yuan (1)
United States (1)
Yuan Yuan, MD (1)